Supporting note 1: Materials and Methods
NAI-N 3 was prepared according to a previously reported procedure (1) and was used as a 2 M solution in dry DMSO. It can also be purchased from Cell Data Sciences. All DNA sequences were purchased from the Integrated DNA Technologies (IDT) and were purified by polyacrylamide gel electrophoresis (PAGE) in denaturing 20% gel. The Molecular Beacon probe was purchased from Sigma Aldrich. GFP-sgRNA (chemically modified on the three last nucleotides at both ends) was purchased from Synthego. Cas9 mRNA (CleanCap Cas9 mRNA, L-7606-100) was purchased from Trilink Biotechnologies. Cas9 nuclease for in vitro assays and for CRISPR-Cas9 in cell studies were purchased from Agilent (Cat# 5190-7717) and
Synthego (Cas9 nuclease 2NLS, S. pyogenes), respectively. Oligonucleotide concentrations were measured using a NanoDrop One microvolume UV-Vis spectrophotometer. Where available, molar concentrations were calculated based on Cy5 absorbance.
Fluorescence studies were performed on a Fluorolog 3-11 instrument (Jobin Yvon-SPEX). All gels were visualized and their fluorescence (Cy5 or SYBR Gold) were recorded using a Typhoon 9500 laser scanner (GE Healthcare). PAGE gel images were analyzed and quantified with Image J software. All quantitative experiments were performed in triplicate, and the results were averaged. All flow cytometry analysis was done on the Scanford instrument in the Stanford Shared FACS Facility.
Supporting note 2: GFP-sgRNA cloaking using NAI-N 3
2M NAI-N 3 solution in DMSO was added to a solution of GFP-sgRNA (1-5 µg) in MOPS buffer (100 mM HEPES, pH 7.5, 6 mM MgCl 2 , 100 mM NaCl) to a final NAI-N 3 concentration of 200 mM and a total volume of 10 µL. The reaction mixture was incubated at 37 ˚C for 20 minutes, before it was quenched by addition of 90% v:v of 3 M NaOAc followed by 3.75× v:v of ethanol and 1 μL of glycogen (5 mg/mL).
The mixture was incubated at -80 ˚C overnight and centrifuged (21000 RCF) for 1 h at 4 ˚C to obtain the RNA pellet. The pellet was washed with 75% ethanol, dried and resuspended in RNase-free water.
As mentioned in the main text, our general approach here was to titrate levels of acylation so as to suppress bioactivity by >95%, but not overacylate the RNA such that recovery of activity is poor upon phosphine treatment.
Supporting note 3: in vitro Cas9 DNA cleavage assay
In vitro Cas9 DNA cleavage assay was adapted from the protocol provided by Agilent Technologies (2) . In a 10 µL reaction volume, GFP-sgRNA (5 nM) in the presence of Cas9 nuclease (50 nM) and Cy5-labelled target ds-DNA and 1x Cas9 digestion buffer (Agilent) were incubated at 30 °C for 90 minutes. Incubation was then continued at 65 °C for 15 minutes. Upon completion, 1 µL of Proteinase K (New England Biolabs) was added and sample was incubated at 37 °C for 15 minutes. Assay was quenched by addition of 0.1%
S4
Orange G solution in 6.5 M formamide containing 100 mM EDTA and samples were denatured at 95°C before being loaded on 15% denaturing PAGE. Uncleaved DNA substrate and cleavage products were quantified and used to calculate the gene editing efficiency (%) by the formula: (a/b) × 100 where "a" is the sum of the band intensities of the cleavage product and "b" is the sum of band intensities of cleaved and uncleaved DNA. 
Supporting note 6: Cellular CRISPR-Cas9 experiments using CARTs
GFP(+) HeLa cells were cultured at 37 °C, 5% CO2, and 95% humidity. Cells were maintained in supplemented DMEM culture medium (10% FBS, Gibco, 1 × Penicillin/Streptomycin, Thermo Fisher Scientific) and were seeded at a concentration of 4 × 10 4 cells per well in a 24-well plate 16 hours prior to the experiment. Prior to the experiment, cells were rinsed with serum-free media and 400 µL of serum-free media were added to each well. GFP-sgRNA (untreated or cloaked, 120 ng) and Cas9 mRNA (120 ng) were premixed in presence of PBS buffer (pH: 5.5), and were then formulated for CART delivery by being gently S5 vortexed with the D:A 13:11 CART system in a net 10:1 cation:anion ratio (0.31 µL of 2 mM CART solution in DMSO) shortly before the mixture was added to each well. Plates were gently rocked and were then incubated at 37 °C for 4 hours, before their media replaced with 500 µL of supplemented DMEM culture medium (10% FBS, Gibco, 1 × Penicillin/Streptomycin). In order to uncloak GFP-sgRNAs, a solution of THPP or TPPMS phosphines in water was added 4 hours after transfection to the media of cells earlier transfected with cloaked GFP-sgRNA, to a final phosphine concentrations of 5 mM (THPP) or 1 mM (TPPMS). Cells were subsequently incubated at 37 °C for 17 hours, before their media was changed with supplemented DMEM. Cells were then incubated for 5 days until all GFP protein was depleted and were then analyzed by flow cytometry. GFP expression was measured on a Scanford Cytometer at Blue and 10 mM of phosphines THPP and TPPMS for 24h at 37°C and 5% CO 2 , in supplemented DMEM culture medium. Control cells were incubated in the supplemented DMEM with addition of nuclease-free water.
After the incubation period medium was removed and 100 μl of fresh, not supplemented DMEM medium, without phenol red (Gibco) was added to each well. Medium contained 10 nM SYTOX Green and 5 μM C12-resazurin. Plate was incubated for 15 minutes at 37°C and 5% CO 2 in the dark. Fluorescence of the samples was measured using a microplate reader Tecan Infinite M1000 at excitation 480nm, and emissions 530nm for SYTOX Green, and 575nm for resofurin. All samples were prepared in the quintuplicates.
Deiters has previously reported on toxicity of phosphines in a protein uncaging study (Nat. Chem. 2016, 8, 1027). In our cellular experiments, we employed 1 mM phosphine; see Fig. S5 for explicit toxicity data at that concentration. In general we note that there is some phosphine toxicity seen at all concentration ranges, but the fluorescence (flow cytometry) assay takes this into account (above) by measuring the whole population after 5 days.
Supporting note 8: Molecular Beacon study
Molecular beacon fluorescence signals were recorded at λ ex = 496 nm and λ em = 520 nm at 52 °C. The molecular beacon was added to molecular beacon buffer (100 mM Tris-HCl, pH 8, 100 mM NaCl, 5 mM 
Supporting note 9: Analysis of mutagenesis frequencies in RUNX1 gene using CRISPR-Cas9
HEK293T cells (ATCC) were cultured at 37 °C, 5% CO2, and 95% humidity in supplemented DMEM culture medium (10% FBS, Gibco; 1 × Penicillin/Streptomycin, Gibco) and were seeded at a concentration of 2 x 10 4 cells per well in a 24-well plate. After 16 hours cells the DMEM medium was replaced with 500 μL of fresh serum-free medium. The transfection mixture contained: 0.4 μL of sgRNA 1 (untreated or cloaked, 120 ng, Synthego, 2'OmG2'OmC2'OmAUUUUCAGGAGGAAGCGA-Synthego modified EZ scaffold) and 0.6 μL of Cas9 mRNA (600 ng, TriLink) were premixed in presence of 3.7 μL of PBS buffer (pH: 5.5), and were then formulated for CART delivery by being gently flicked for 1 min. with the D:A 13:11 CART system in a net 10:1 cation:anion ratio (0.28 μL of 2 mM CART solution in DMSO) and
immediately added to well. The medium was pipetted three times to mix the transfection mixture well and were incubated at 37 °C for 4 hours, before their media replaced with 500 μL of supplemented DMEM S7 culture medium. In order to uncloak sgRNAs, to cells earlier transfected with cloaked sgRNA was added supplemented medium containing THPP or TPPMS phosphines in concentration 1 mM and 5 mM. Cells were incubated for next 17 hours, before the medium was replaced with a fresh supplemented DMEM.
Cells were then incubated for 5 days. 
